YBEY Antibody

What is YBEY and why are antibodies against it important for research?

YBEY is a single strand-specific metallo-endoribonuclease (EC 3.1.-.-) that plays a crucial role in rRNA maturation . In human cells, YBEY is essential for mitochondrial ribosome biogenesis, particularly for the small ribosomal subunit . Deletion of human YBEY results in severe respiratory deficiency and morphologically abnormal mitochondria, primarily due to impaired mitochondrial translation . Antibodies against YBEY are vital research tools that enable the detection, localization, and functional characterization of this protein in various experimental contexts, helping researchers understand its role in mitochondrial function and related disease processes.

What types of YBEY antibodies are available for research applications?

Several types of YBEY antibodies are available for research use, including:

• Unconjugated polyclonal antibodies raised in rabbits with reactivity against human YBEY, suitable for ELISA and IHC applications

• HRP-conjugated polyclonal antibodies for enhanced detection in ELISA and other applications requiring enzymatic amplification

• FITC-conjugated antibodies for fluorescence-based detection methods, particularly useful in immunofluorescence microscopy

These antibodies provide researchers with flexibility in experimental design depending on the detection method and specific application requirements.

How are YBEY knockout models generated for functional studies?

Researchers have employed several gene editing approaches to generate YBEY knockout models:

• CRISPR/Cas9 technology has been used to create YBEY knockout Hap1 cells through the introduction of frameshift mutations. In one documented case, a 31 bp insertion and 1 bp mutation produced a premature stop codon, resulting in an 80 amino acid truncated protein .

• Zinc finger nuclease (ZFN) targeting exon 2 has been utilized to modify the YBEY locus in HEK293T cells . Due to the polyploidy of HEK293T cells at the YBEY locus on chromosome 21, researchers have generated partially deficient cell lines with various indels leading to premature stop codons or amino acid changes .

These genetic models provide valuable tools for investigating the consequences of YBEY deficiency in cellular systems.

What validation methods should be applied when using YBEY antibodies?

When using YBEY antibodies, researchers should implement several validation approaches:

• Western blotting to confirm specificity and absence of cross-reactivity with other proteins

• Comparison of antibody reactivity between wild-type cells and YBEY knockout or knockdown models

• Testing for expected molecular weight detection (~19.3 kDa for human YBEY)

• When possible, validate antibody performance across multiple applications (ELISA, IHC, WB) to ensure consistent reactivity

• For localization studies, confirm mitochondrial targeting using co-localization with established mitochondrial markers

These validation steps are essential for producing reliable and reproducible research findings when using YBEY antibodies.

How can researchers use YBEY antibodies to investigate mitochondrial ribosome assembly?

YBEY antibodies can be instrumental in studying mitochondrial ribosome assembly through several advanced experimental approaches:

• Immunoprecipitation combined with mass spectrometry to identify YBEY-interacting proteins during ribosome assembly

• Proximity labeling techniques (BioID or APEX) using YBEY as bait to map the spatial organization of assembly factors

• Chromatin immunoprecipitation followed by sequencing (ChIP-seq) to identify YBEY binding sites on mitochondrial rRNA

• Super-resolution microscopy with fluorophore-conjugated YBEY antibodies to visualize the spatial and temporal dynamics of ribosome assembly

Research has shown that YBEY deletion impairs the stability of 12S rRNA and reduces several proteins of the small ribosomal subunit, indicating its critical role in mitochondrial ribosome assembly . These approaches allow researchers to dissect the molecular mechanisms by which YBEY facilitates proper ribosome formation.

What experimental approaches can determine how YBEY mutations affect protein function?

To investigate the impact of YBEY mutations on protein function, researchers can employ the following strategies:

• Site-directed mutagenesis to introduce specific mutations (such as R55A and H128A) in YBEY expression constructs

• Complementation studies in YBEY knockout cells to assess whether mutant variants can rescue the phenotype

• In vitro endoribonuclease assays to measure enzymatic activity of purified wild-type versus mutant YBEY proteins

• Structural studies (X-ray crystallography or cryo-EM) to determine how mutations affect protein conformation

Complementation strategies have been successfully implemented using linearized plasmids (e.g., ScaI-linearized pcDNA4-YBEY, pcDNA4-YBEY-R55A, or pcDNA4-YBEY-H128A) transfected into YBEY knockout cells, followed by selection with appropriate antibiotics (5 μg/ml blasticidin and 100 μg/ml zeocin) . Western blotting with YBEY antibodies can then confirm expression levels of the mutant proteins.

How can researchers quantitatively assess YBEY expression changes in disease models?

Quantitative assessment of YBEY expression in disease models can be accomplished through:

• Western blotting with YBEY antibodies followed by densitometric analysis, normalized to appropriate loading controls

• Quantitative real-time PCR to measure YBEY mRNA levels

• Proteomics approaches such as SILAC or TMT labeling combined with mass spectrometry

• Immunohistochemistry with YBEY antibodies on tissue sections, followed by digital image analysis for quantification

What strategies can optimize YBEY antibody performance in challenging applications?

For challenging applications involving YBEY antibodies, researchers should consider:

• For low-abundance detection:

  • Signal amplification methods such as tyramide signal amplification for IHC

  • Concentrated antibody solutions for difficult-to-detect samples

  • Extended incubation times at optimal temperatures

• For high background reduction:

  • Extended blocking steps with 5% BSA or normal serum

  • Additional washing steps with increased detergent concentration

  • Titration experiments to determine optimal antibody concentration

• For co-localization studies:

  • Sequential staining protocols to minimize cross-reactivity

  • Careful selection of compatible fluorophores to avoid spectral overlap

  • Super-resolution microscopy techniques for improved spatial resolution

• For protein-protein interaction studies:

  • Optimized lysis conditions to preserve native protein complexes

  • Pre-clearing lysates before immunoprecipitation

  • Using magnetic beads instead of agarose for cleaner precipitates

Each application may require specific optimization strategies to maximize signal-to-noise ratio and ensure reliable results.

What are the critical controls for validating YBEY knockout models?

When validating YBEY knockout models, researchers should incorporate these essential controls:

• Genomic verification:

  • PCR amplification and sequencing of the targeted YBEY locus

  • Analysis of potential off-target modifications

• Protein expression verification:

  • Western blotting with validated YBEY antibodies

  • Mass spectrometry-based proteomics to confirm protein absence

• Functional validation:

  • Assessment of mitochondrial translation efficiency

  • Measurement of respiratory capacity

  • Analysis of mitochondrial morphology

• Rescue experiments:

  • Complementation with wild-type YBEY to confirm phenotype specificity

  • Use of catalytically inactive mutants as negative controls

In published studies, researchers have validated YBEY knockout cells using PCR with specific primers (e.g., YBEY_6f primers) that yield differently sized products for wild-type (486 bp) versus disrupted alleles (201 bp, 31 bp, or 130 bp, depending on the specific modification) . This genomic validation should be complemented with protein-level verification using western blotting with YBEY antibodies.

How can researchers analyze YBEY's impact on mitochondrial translation?

To analyze YBEY's impact on mitochondrial translation, the following methodological approaches can be employed:

• Metabolic labeling:

  • Pulse labeling with 35S-methionine/cysteine in the presence of cytoplasmic translation inhibitors

  • Analysis of newly synthesized mitochondrial proteins by SDS-PAGE and autoradiography

• Ribosome profiling:

  • Isolation of mitochondrial ribosomes and sequencing of ribosome-protected mRNA fragments

  • Computational analysis to identify translation efficiency changes

• Polysome profiling:

  • Sucrose gradient fractionation of mitochondrial lysates

  • Analysis of ribosomal subunit assembly and polysome formation

• Proteomics:

  • Stable isotope labeling approaches to measure synthesis rates of mitochondrial proteins

  • Targeted proteomics to quantify specific mitochondrially-encoded proteins

Research has demonstrated that YBEY deletion results in a severe reduction in mitochondrial translation and loss of cell viability . These methodologies can help elucidate the mechanistic details of how YBEY contributes to proper mitochondrial translation.

What techniques are most effective for studying YBEY's endoribonuclease activity?

To characterize YBEY's endoribonuclease activity, researchers can utilize these techniques:

• In vitro RNA cleavage assays:

  • Incubation of purified recombinant YBEY protein with radiolabeled or fluorescently-labeled RNA substrates

  • Analysis of cleavage products by denaturing gel electrophoresis

• Structure-function studies:

  • Site-directed mutagenesis of conserved catalytic residues (e.g., R55A, H128A)

  • Complementation assays in YBEY knockout cells expressing mutant proteins

• RNA immunoprecipitation:

  • Cross-linking of YBEY to RNA in vivo

  • Immunoprecipitation with YBEY antibodies followed by RNA sequencing to identify substrates

• CRISPR-based screens:

  • Genome-wide screens to identify genetic interactions with YBEY

  • Analysis of synthetic lethal or suppressor interactions

For producing recombinant YBEY for in vitro studies, cell-free protein synthesis systems have been used to generate full-length human YBEY (167 amino acids) with purification tags such as Strep-Tag . These purified proteins can then be used in biochemical assays to characterize enzymatic properties.

How should experiments be designed to study YBEY's role in different cellular compartments?

When investigating YBEY's role across cellular compartments, consider these experimental design approaches:

• Subcellular fractionation:

  • Differential centrifugation to isolate mitochondria, cytosol, and other compartments

  • Western blotting with YBEY antibodies to determine localization

  • Use of compartment-specific markers for validation

• Immunofluorescence microscopy:

  • Co-staining with compartment markers (MitoTracker for mitochondria, DAPI for nucleus)

  • Super-resolution techniques for precise localization

  • Live-cell imaging with fluorescently-tagged YBEY

• Proximity labeling:

  • Expression of YBEY fused to BioID or APEX in different cellular compartments

  • Identification of proximal proteins by mass spectrometry

  • Validation of interactions with co-immunoprecipitation using YBEY antibodies

• Conditional targeting:

  • Creation of YBEY constructs with different targeting sequences

  • Functional complementation assays with compartment-specific variants

These approaches can help determine if YBEY functions primarily in mitochondria or has additional roles in other cellular compartments.

What are the common challenges and solutions when working with YBEY antibodies?

Researchers commonly encounter these challenges when working with YBEY antibodies:

Additional troubleshooting tips include thorough validation of antibodies using knockout controls, optimization of incubation times and temperatures, and careful selection of detection methods appropriate for the expected expression levels of YBEY.

How can researchers study the relationship between YBEY and mitochondrial disorders?

To investigate YBEY's role in mitochondrial disorders, researchers can employ these methodological approaches:

• Patient sample analysis:

  • Sequencing of YBEY in patients with unexplained mitochondrial disorders

  • Measurement of YBEY protein levels using validated antibodies

  • Correlation of YBEY variants with clinical phenotypes

• Disease modeling:

  • Creation of cellular models expressing disease-associated YBEY variants

  • Assessment of mitochondrial function in these models

  • Complementation studies to determine variant pathogenicity

• Phenotypic analysis:

  • Respiratory chain complex activity measurements

  • Mitochondrial membrane potential assessment

  • Analysis of reactive oxygen species production

• Multi-omics approaches:

  • Integration of transcriptomics, proteomics, and metabolomics data

  • Network analysis to identify perturbed pathways

  • Correlation with clinical parameters

Research has demonstrated that YBEY deficiency leads to severe respiratory deficiency and abnormal mitochondrial morphology , suggesting that YBEY dysfunction could contribute to mitochondrial disease pathogenesis. These methodologies can help establish concrete links between YBEY variants and specific mitochondrial disorders.

How can YBEY antibodies be used in high-throughput screening applications?

YBEY antibodies can be adapted for high-throughput screening through these methodological approaches:

• Automated immunofluorescence:

  • Robotics-assisted immunostaining with YBEY antibodies

  • High-content imaging and analysis

  • Machine learning algorithms for phenotype classification

• ELISA-based screens:

  • Development of sandwich ELISA with YBEY antibodies

  • Adaptation to 384-well or 1536-well formats

  • Automated liquid handling for increased throughput

• Protein microarrays:

  • Spotting of compounds or genetic elements on arrays

  • Detection of YBEY levels or modifications using specific antibodies

  • Multiplexed analysis of multiple targets simultaneously

• Flow cytometry:

  • Intracellular staining with YBEY antibodies

  • Multi-parameter analysis with additional markers

  • Cell sorting based on YBEY expression levels

These high-throughput approaches can enable screening of chemical libraries for compounds that modulate YBEY function or identification of genetic factors that influence YBEY expression and activity.

What are the methodological considerations for studying YBEY in different model organisms?

When investigating YBEY across different model organisms, researchers should consider:

• Cross-reactivity evaluation:

  • Test whether human YBEY antibodies recognize orthologous proteins

  • Western blotting with lysates from different species

  • Epitope conservation analysis through sequence alignment

• Model-specific genetic tools:

  • CRISPR/Cas9 approaches tailored to each model organism

  • RNA interference strategies where applicable

  • Transgenic approaches for overexpression studies

• Experimental readouts:

  • Species-appropriate assays for mitochondrial function

  • Consideration of physiological differences between models

  • Adaptation of biochemical assays to different tissue types

• Evolutionary context:

  • Comparative analysis of YBEY function across species

  • Consideration of lineage-specific adaptations in mitochondrial biology

While YBEY is highly conserved from bacteria to humans, important structural and functional differences may exist that require careful experimental design and interpretation.

What emerging technologies might enhance YBEY antibody-based research?

Several emerging technologies hold promise for advancing YBEY research:

• Single-cell proteomics:

  • Analysis of YBEY expression at single-cell resolution

  • Correlation with mitochondrial heterogeneity

  • Integration with single-cell transcriptomics

• Advanced imaging technologies:

  • Super-resolution microscopy beyond the diffraction limit

  • Expansion microscopy for enhanced spatial resolution

  • Live-cell imaging with improved temporal resolution

• Nanobody and aptamer development:

  • Generation of smaller binding molecules against YBEY

  • Improved penetration into subcellular compartments

  • Enhanced specificity through directed evolution

• CRISPR-based technologies:

  • Base editing for precise YBEY modifications

  • CRISPRi/CRISPRa for reversible modulation of expression

  • CRISPR screens to identify genetic interactions

These technologies can overcome current limitations in studying YBEY biology and provide more precise insights into its function in health and disease.

How should researchers interpret conflicting results in YBEY functional studies?

When faced with conflicting results in YBEY research, consider these methodological approaches:

• Critical evaluation of experimental systems:

  • Cell type differences (e.g., HEK293T versus Hap1 cells)

  • Complete versus partial knockout effects

  • Acute versus chronic loss of function

• Technical variables:

  • Antibody specificity and validation methods

  • Assay sensitivity and dynamic range

  • Experimental conditions and timing

• Biological context:

  • Compensatory mechanisms in different models

  • Cell state and metabolic conditions

  • Genetic background effects

• Integration of multiple approaches:

  • Combination of genetic, biochemical, and imaging methods

  • Use of complementary techniques to address the same question

  • Consideration of both gain- and loss-of-function approaches